AOD-9604 5MG
AOD-9604 5MG is a research-grade peptide studied for its selective fat metabolism and metabolic regulation properties. Supplied exclusively for in-vitro and laboratory research use by Blue Ridge Peptides.
⚠️ RESEARCH USE ONLY
This product is for R&D purposes only and is not approved for human or veterinary use.
AOD-9604 5MG – Research Grade Peptide
AOD-9604 is a synthetic fragment of human growth hormone (residues 176–191) developed for its lipolytic properties without the anabolic effects of full-length growth hormone. It has been studied in preclinical and clinical research models for its selective action on fat metabolism.
Research indicates that AOD-9604 can promote reductions in body fat and improve metabolic markers while showing minimal effects on insulin-like growth factor-1 (IGF-1) signaling. These studies focus on understanding the peptide’s influence on lipolysis and lipid regulation pathways under controlled experimental conditions.
Ongoing scientific investigations continue to explore AOD-9604’s mechanisms of action, receptor interactions, and potential relevance in metabolic research and weight regulation models. All observations referenced in the literature are derived from non-clinical and experimental research settings.
Blue Ridge Peptides supplies AOD-9604 5MG strictly for laboratory research, analytical testing, and in-vitro scientific investigation. This material is not intended for human or animal use and is not approved for therapeutic or diagnostic applications.
For research use only. Not for human or animal consumption.
AOD-9604 5MG – Research Grade Peptide
AOD-9604 is a synthetic fragment of human growth hormone (residues 176–191) developed for its lipolytic properties without the anabolic effects of full-length growth hormone. It has been studied in preclinical and clinical research models for its selective action on fat metabolism.
Research indicates that AOD-9604 can promote reductions in body fat and improve metabolic markers while showing minimal effects on insulin-like growth factor-1 (IGF-1) signaling. These studies focus on understanding the peptide’s influence on lipolysis and lipid regulation pathways under controlled experimental conditions.
Ongoing scientific investigations continue to explore AOD-9604’s mechanisms of action, receptor interactions, and potential relevance in metabolic research and weight regulation models. All observations referenced in the literature are derived from non-clinical and experimental research settings.
Blue Ridge Peptides supplies AOD-9604 5MG strictly for laboratory research, analytical testing, and in-vitro scientific investigation. This material is not intended for human or animal use and is not approved for therapeutic or diagnostic applications.
For research use only. Not for human or animal consumption.
Research Overview
AOD-9604 is primarily studied in experimental models focused on fat metabolism, adipose tissue signaling, and selective lipolytic activity. Its design as a truncated fragment of human growth hormone makes it a valuable research tool for investigating lipid regulation without anabolic effects.
Key Research Focus Areas
- Fat Metabolism Studies: Studied for its ability to modulate lipolysis and lipogenesis pathways.
- Body Composition Research: Examined for effects on adipose tissue regulation and fat reduction mechanisms.
- Metabolic Signaling Studies: Investigated for its impact on cellular energy utilization and metabolic markers.
- Endocrine System Models: Explored for its selective interaction with growth hormone-related pathways.
- Preclinical and Clinical Research: Used to evaluate safety, tolerability, and mechanistic insights under experimental conditions.
Because AOD-9604 acts selectively on fat metabolism without stimulating systemic growth pathways, it is commonly utilized as a research tool in metabolic and adipose-focused studies.
